1. V Zemskov (1969). The effect of yeast RNA on the outcome of an experimental infection in mice. Journal of Microbiology, 8, 84-89.
2. V Zemskov (1970). Increased Anti-Infectious resistance mice using heterologous RNA. Journal of Microbiology, 2, 33-37.
3. A Zemskov,V Zemskov,V Zemskova,R Sepiashvili,V Zoloedov (1970). INFECTION AND IMMUNITY IN PATIENTS WITH RISK GROUPS. Journal of microbiology, epidemiology and immunobiology, 95(2), 109-119.
4. V Zemskov (1972). Increasing resistance to infections with nucleic acid preparations. Bulletin of Experimental Biology and Medicine, 73(4), 430-432.
5. V Zemskov (1974). Effect of yeast RNA on virulent staphylococci in vivo and in vitro. Journal of Microbiology, 10, 96-99.
6. V Zemskov (1975). Bacterial populations and nucleic acids. Successes of Modern Biology, 79(2), 241-251.
7. V Zemskov (1977). RNA-induced intensification of antibacterial resistance and aggravation of infection. J Hyg Epidemiol Microbiol Immunol, 21(2), 195-202.
8. V Zemskov,A Zemskov (1992). Immunomodulating effects of a low molecular weight RNA. Soviet Medical Reviews / Section D. Immunology. Reviews, 3, 113.
9. V Zemskov,V Shilov,N Tsyganova,N Korabelnikova,L Fadeeva,E Sklyanskaya,V Prokhorov,Ya (1974). O:4 – Bacterial infections. Clinical Microbiology and Infection, 6, 36-37.
10. V Zemskov,A Barsukov,V Shilov,A Zemskov,A Pokrovsky (1977). Increasing resistance to infections with nucleic acid preparations. Bulletin of Experimental Biology and Medicine, 73(4), 430-432.
11. V Zemskov,T Balezina,L Korneeva,G Loiidina,O Nikolaeva,S Fainstein,L Fadeeva,Z Ermolieva (1977). Inducing activity and antiviral effect of tobacco mosaic-virus, tilorone, and sodium nucleinate. Acta virologica, 21(4), 338-343.
12. V Zemskov,Yu Pritulina,N Polikarpov (1978). The intensification of experimental dysenteric infection in mice and the acceleration of the multiplication of pathogenic and conditionally pathogenic bacteria under the influence of yeast RNA. Journal of Microbiology, 1, 97-102.
13. V Zemskov,A Barsukov,V Sobolev (1978). Mechanistic Diversity of Fosfomycin Resistance in Pathogenic Microorganisms. Antibiotics, 6, 520-526.
14. V Zemskov,M Lidak,Yu,A Zemskov,U Mikstas (1985). Low molecular weight RNA. Obtaining, hydrolysis, and use in medicine. Low molecular weight RNA. Obtaining, hydrolysis, and use in medicine, 191.
15. Vladimir Zemskov,Vladimir Zemskov,Viktoria Neymann,Konstantin N Pronko,Andrey M Zemskov,Andrey A Alekseev (2007). Non-Lymphoid Components of Immunopathology. Surgical Case Reports, 1-2.
16. V Zemskov (1975). Increasing resistance to infections with nucleic acid preparations. Bulletin of Experimental Biology and Medicine, 73(4), 430-432.
17. Andrey Zemskov,Vladimir Zemskov,Veronika Zemskova,Zoya Vorontsova,Yevgeniy Dorokhov,Igor Chernitsyn (1992). Non-pharmacological immunocorrection. International Journal of Recent Scientific Research, 08(05), 17140-17145.
18. A Zemskov,V Zemskov,V Vornovskii (1995). Typical Reactions of the Immune System in Disease. Human Physiology, 27(1), 102-109.
19. V Zemskov,A Barsukov,S Pal'mina,L Fadeeva,M Maksudova,S Yarotskii (1978). Enhancement of antibacterial and antiviral resistance and immune response by a pharmacopoeial preparation of RNA. Bulletin of Experimental Biology and Medicine, 87(3), 250-252.
20. V Zemskov,A Barsukov,V Sobolev (1979). New data on the tachyphylaxis properties of sodium nucleinate. Journal of Microbiology, 4, 43-46.
21. V Zemskov,A Barsukov,S Beznosenko,E Pisklova (1981). Activation of spontaneous leukocyte migration by sodium nucleinate. Immunology, 3, 51-55.
22. V Zemskov,N Medunitsyn,L Alekseev,I Podoplelov,O Krylov,A Vedernikov,U Mikstays,Ya (1988). Stimulation cellular immunity of low molecular weight RNA and its mononucleotide. Immunology, 1, 27-30.
23. A Zemskov,V Zemskov,A Nikitin,V Zazhirey,E Evstratova (1989). Combined immunomodulating therapy timoptic and sodium nucleinate of patients with chronic bronchitis. Therapeutic Archive, 3, 65-68.
24. A Zemskov,V Zemskov (1995). An integral concept of regulating immune homeostasis. Biology Bulletin Reviews, 4(6), 467-476.
25. V Zemskov,A Zemskov,K Pronko,S Afanasiev,V Zelkova,A Revishvili,Sh (2019). Controversial issues of clinical immunology. Modern concepts about the pathogenesis of infections. Global Journal of Medical Research: C Microbiology and Pathology, 19(2), 1-6.
26. N Kochergina,A Yarilin,V Zemskov,U Mikstays,Ya (1986). Analysis of the cellular basis of the action of sodium nucleinate, purine, and pyrimidine nucleotides on the humoral immune response. Immunology, 5, 34-37.
27. A Zemskov,V Provotorov,A Nikitin,E Evstratova,V Zemskov (1984). Sodium nucleinate correction immunosuppressive effects of drugs. Immunology, 4, 76-79.
28. L Bogdanova,V Sobolev,V Zemskov (1980). Combination antibiotics and sodium nucleinate in the treatment of mixed infection caused by pyogenic bacteria in the experiment. Antibiotics, 12, 921-924.
29. A Zemskov,V Zemskov (1987). The development of the experimental clinical studies of low molecular weight RNA. Zhurn. Microbiologic, 3, 104-110.
30. Ladimir Zemskov,Konstantin Pronko,Andrey Zemskov,Veronika Zemskova (1981). Complexity problem in immunology. Australasian Medical Journal, 11(9), 52-55.
31. V Zemskov,S Rodionov,V Pantin (1985). Redistribution and activation of peritoneal macrophages during oral administration of sodium nucleinate. Journal of Microbiology, 8, 46-50.
32. V Zemskov,S Rodionov,V Pantin,A Khramtsov,U Mikstays,Ya (1985). Quantitative biochemical analysis of macrophages of mice stimulated with sodium nucleinate. Immunology, 6, 55-58.
33. E Sherbakova,V Zemskov,V Sobolev,G Rastunova,A Barsukov (1981). Histochemical study of peritoneal macrophages activated by sodium nucleinate. Antibiotics, 3, 119-123.
34. V Zemskov,A Zemskov (2014). Contemporary concept and general regularities of immunomodulating therapy. Biology Bulletin Reviews, 4(4), 276-284.
35. A Zemskov,V Zemskov,M Zemskov,V Zemskova,V Zoloedov (1982). Modification of clinical and laboratory status and its correction in patients with the featured clinical course of asthma. Biology Bulletin Reviews, 7(6), 519-527.
36. M Zemskov,V Zemskov,Z Gurina,A Nerobeev (1982). The use of sodium nucleinate in the treatment of periodontal disease. Dental Guia, 2, 23-25.
37. V Zemskova,A Zemskov,V Zemskov,Vladimir Zoloedov (1993). The actual problems of immune therapy of pyo-inflammatory diseases. Medical Journal of the Russian Federation, 22(2), 70-74.
38. A Zemskov,V Zemskov,V Zemskova (1994). Mechanisms of the Formation, Regulation, and Address Correction of Immune Disorders. Biology Bulletin Reviews, 9(2), 166-173.
39. A Zemskov,V Zemskov,M Zemskov,V Zemskova,V Zoloedov (1994). Modification of clinical and laboratory status and its correction in patients with the featured clinical course of asthma. Biology Bulletin Reviews, 7(6), 519-527.
40. V Zemskov,A Nikitin,A Zemskov,V Alabovsky,V Gusmanov,B Trunov (1994). The effect of sodium nucleinate on ventricular arrhythmias and the level of medium molecular peptides of blood in the experiment. Pathophysiology and Experimental Therapy, 3, 31-33.
41. A Zemskov,V Zemskov,V Zemskova,V Zoloedov,E Dorohov (2000). Immunoglobulins – present and future. International Journal of Current Advanced Research, 6(4), 3400-3404.
42. A Zemskov,V Zemskova,V Zemskov (2013). Unorthodox Phenomena of Clinical Immunology. Biology Bulletin Reviews, 10(6), 534-542.
43. Vladimir Zemskov,Zemskov,Andrey,Alexander Glukhov (2014). Diagnosis, treatment of immunodependent, associated immune diseases. Basics, characteristics, methods. Diagnosis, treatment of immunodependent, associated immune diseases. Basics, characteristics, methods, 641, 320.
44. A Zemskov,V Zemskov (2016). An integral concept of regulating immune homeostasis. Biology Bulletin Reviews, 4(6), 467-476.
45. N Kanchurina,V Zemskov,Yu Poroshina,A Kiryukhin,Yu,Yu Volkov,E Torina,O Belostotskaya,N Prosolova (1995). Sodium nucleinate in the treatment of asthmatic triad (AT). Internat J of Immunorehabilitation, 1, 52.
46. A Mayorov,Yu Poroshina,V Zemskov (1992). Abstracts of the European Academy of Allergology and Clinical Immunology, Congress, Paris, 10–15 May 1992. Allergy, 47(6), 663-697.
47. V Provotorov,A Zemskov,A Nikitin,E Evstratova,E Zhigulskaya,V Zemskov (1984). Correction nucleinate sodium immunological deficiency in patients with bronchopulmonary pathology. Immunology, 1, 75-78.
48. A Revishvili,Sh,V Zemskov,A Zemskov (2018). Problems of clinical immunology of the XXI -Century II. Problems of clinical immunology of the XXI -Century II, 286.
49. A Revishvili,Sh,V Zemskov,A Zemskov (2018). Problems 21st Century clinical 44. Problems 21st Century clinical 44
50. Vladimir Zemskov,Andrey Zemskov (2016). Tactic- and Strategy-affiliated Policy to Drive Clinical Immunology Ahead and to Secure the Future. Anatomy & Physiology, 6(3), 3-8.
